Trial Profile
Rituxan injection drug use-results survey in patients with complicated nephrotic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Nephrotic syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Zenyaku Kogyo
- 05 Mar 2019 Status changed from recruiting to completed.
- 01 Sep 2014 New trial record